Dr. Anita Bhattacharyya, an associate professor of cell and regenerative biology in the school of medicine and public health at the University of Wisconsin-Madison, said she was hoping to apply for a future NIH grant to study human fetal tissue research and will now not be able to do so.
Bhattacharyya explained she currently uses human-induced pluripotent stem cells, which are reprogrammed cells that are similar to embryonic stem cells, in her work. However, the loss of NIH funding for human fetal tissue research could affect future work.
“My reaction was, ‘How are we going to do some of our research if we can no longer use human fetal tissue?'” she recalled to ABC News. “In particular, my lab studies Down syndrome and so we know that in Down syndrome, the brain develops differently to lead to the intellectual disability that people with Down syndrome have.”